PLPengfei Luan

Pengfei Luan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pengfei Luan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hong Zhu

    Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, China

    2 shared publications
  • Jie Dang

    Department of Medical Genetics and Cell Biology, College of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China

    2 shared publications
  • Jing Zhang

    Department of Medical Genetics and Cell Biology, College of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China

    2 shared publications
  • Qian Ma

    Department of Medical Genetics and Cell Biology, College of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China

    2 shared publications
  • Shaolan Zhou

    Department of Medical Genetics and Cell Biology, College of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China

    2 shared publications
  • Yanfeng Wang

    Department of Medical Genetics and Cell Biology, College of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, China

    2 shared publications

Latest Publications

  • Open Access

    Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”

    by Shaolan Zhou, Jing Zhang, Pengfei Luan, Zhanbing Ma, Jie Dang, Hong Zhu, Qian Ma, Yanfeng Wang, Zhenghao Huo

    [This corrects the article DOI: 10.1155/2021/5547635.].


  • Open Access

    miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus

    by Shaolan Zhou, Jing Zhang, Pengfei Luan, Zhanbing Ma, Jie Dang, Hong Zhu, Qian Ma, Yanfeng Wang, Zhenghao Huo

    Objective. To investigate microRNA (miRNA) expression profiles in individuals with systemic lupus erythematosus (SLE) and identify the valuable miRNA biomarkers in diagnosing and monitoring SLE. Methods. Next-generation sequencing (NGS) was performed to assess miRNA amounts in peripheral blood mononuclear cells (PBMCs) from four SLE cases and four healthy controls. Quantitative polymerase chain reaction (qPCR) was carried out for validating candidate miRNAs in 32 SLE cases and 32 healthy controls. In addition, receiver operating characteristic (ROC) curve analysis was completed to evaluate diagnostic performance. Finally, the associations of candidate miRNAs with various characteristics of SLE were analyzed. Results. A total of 157 miRNAs were upregulated, and 110 miRNAs were downregulated in PBMCs from SLE cases in comparison to healthy controls, of which the increase of miR-183-5p and decrease of miR-374b-3p were validated by qPCR and both showed good diagnostic performance for SLE diagnosis. Besides, miR-183-5p expression levels displayed a positive association with SLE disease activity index (SLEDAI) and anti-dsDNA antibody amounts. Conclusion. Our data indicated that miR-183-5p is a promising biomarker of SLE.